{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:11:48Z","timestamp":1779887508186,"version":"3.53.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Dutch Governmental Organization for Health Research"},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["848015009"],"award-info":[{"award-number":["848015009"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n The use of oral antimicrobial agents in patients with short bowel syndrome (SBS) is challenging due to the changes in gastrointestinal anatomy that may result in diminished absorption and altered drug bioavailability. Prospective studies evaluating bioavailability of antimicrobial agents after oral administration in SBS patients are lacking.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To determine the bioavailability of orally administered antimicrobial agents commonly used for treatment in SBS patients to guide clinical decision making when faced with infections.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We performed an explorative, clinical study investigating the pharmacokinetics (PK) of clindamycin, ciprofloxacin, flucloxacillin and fluconazole in SBS patients with intestinal failure. Participants received a combination of two antimicrobial agents simultaneously. To determine the oral bioavailability, participants received a single oral and IV dose of both agents on two occasions, after which they underwent intensive PK sampling on six predefined time points up to 12 hours after administration. Primary outcome was the oral bioavailability of these antimicrobial agents. Secondary outcomes were intravenous PK characteristics following non-compartmental analysis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Eighteen SBS patients were included: the mean (SD) age was 59 (17) years and 61% of participants were female. The median observed (IQR) bioavailability of ciprofloxacin, clindamycin, flucloxacillin and fluconazole were 36% (24\u201350), 93% (56\u2013106), 50% (32\u201376) and 98% (61\u2013107), respectively.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The bioavailability of selected antimicrobial agents in certain patients with SBS appeared to be better than expected, providing a feasible treatment option. Due to the large observed differences between patients, therapeutic drug monitoring should be part of the treatment to safeguard adequate exposure in all patients.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Registered in the Dutch Trial Register (NL7796) and EudraCT number 2019-002587-28<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/jac\/dkad198","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T19:06:56Z","timestamp":1688152016000},"page":"2008-2014","source":"Crossref","is-referenced-by-count":8,"title":["Oral antimicrobial agents in patients with short bowel syndrome: worth a try!"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-1172","authenticated-orcid":false,"given":"Julia W","family":"Korzilius","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Radboud university medical center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-5437","authenticated-orcid":false,"given":"Michelle","family":"Gompelman","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Radboud university medical center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7370-0556","authenticated-orcid":false,"given":"Guus T J","family":"Wezendonk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Radboud university medical center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-9892","authenticated-orcid":false,"given":"Nynke G L","family":"Jager","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Medical Innovation, Radboud university medical center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-6262","authenticated-orcid":false,"given":"Chantal P","family":"Rovers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Radboud university medical center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-725X","authenticated-orcid":false,"given":"Roger J M","family":"Br\u00fcggemann","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud Institute for Medical Innovation, Radboud university medical center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5918-5594","authenticated-orcid":false,"given":"Geert J A","family":"Wanten","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Radboud university medical center , Nijmegen , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"2024051617490215300_dkad198-B1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN Guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"key":"2024051617490215300_dkad198-B2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0148607194018003256","article-title":"Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors","volume":"18","author":"O\u2019Keefe","year":"1994","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2024051617490215300_dkad198-B3","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jac\/dks145","article-title":"Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics","volume":"67","author":"Buyle","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2024051617490215300_dkad198-B4","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4081\/idr.2017.6821","article-title":"A systematic review of quality indicators for appropriate antibiotic use in hospitalized adult patients","volume":"9","author":"Kallen","year":"2017","journal-title":"Infect Dis Rep"},{"key":"2024051617490215300_dkad198-B5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1053\/gast.2003.50139","article-title":"American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation","volume":"124","author":"American Gastroenterological Association","year":"2003","journal-title":"Gastroenterology"},{"key":"2024051617490215300_dkad198-B6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11605-009-1151-9","article-title":"The impact of intestinal failure on oral drug absorption: a review","volume":"14","author":"Ward","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"2024051617490215300_dkad198-B7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13318-021-00696-y","article-title":"Changes of drug pharmacokinetics in patients with short bowel syndrome: a systematic review","volume":"46","author":"Hong","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2024051617490215300_dkad198-B8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2165\/00003088-200443140-00001","article-title":"Enteral drug absorption in patients with short small bowel: a review","volume":"43","author":"Severijnen","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"2024051617490215300_dkad198-B9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00003088-197702010-00004","article-title":"Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes","volume":"2","author":"Parsons","year":"1977","journal-title":"Clin Pharmacokinet"},{"key":"2024051617490215300_dkad198-B10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0022-3468(84)80023-8","article-title":"Bioavailability of oral antibiotics in children with short-bowel syndrome","volume":"19","author":"Menardi","year":"1984","journal-title":"J Pediatr Surg"},{"key":"2024051617490215300_dkad198-B11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jps.2600820902","article-title":"Gastrointestinal parameters that influence oral medications","volume":"82","author":"Dressman","year":"1993","journal-title":"J Pharm Sci"},{"key":"2024051617490215300_dkad198-B12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/j.1536-4801.1993.tb10840.x","article-title":"Extreme short bowel syndrome: a case for reviewing the guidelines for predicting survival","volume":"16","author":"Iacono","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024051617490215300_dkad198-B13","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/33.5.1070","article-title":"Systemic absorption of oral fluconazole after gastrointestinal resection","volume":"33","author":"Joe","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"2024051617490215300_dkad198-B14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s13318-021-00715-y","article-title":"Oral antibiotics in patients with short bowel syndrome: do or don\u2019t?","volume":"46","author":"Gompelman","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2024051617490215300_dkad198-B15","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"2024051617490215300_dkad198-B16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bpg.2016.02.011","article-title":"Definitions of intestinal failure and the short bowel syndrome","volume":"30","author":"Pironi","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2024051617490215300_dkad198-B17","author":"Agency EM","year":"2011"},{"key":"2024051617490215300_dkad198-B18","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/ajcn\/nqz036","article-title":"Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a model for end-stage intestinal failure (MESIF risk score)","volume":"109","author":"Koelfat","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"2024051617490215300_dkad198-B19","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.2000.20227","article-title":"Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans","volume":"119","author":"Crenn","year":"2000","journal-title":"Gastroenterology"},{"key":"2024051617490215300_dkad198-B20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2165\/00003088-199019060-00003","article-title":"Clinical pharmacokinetics of ciprofloxacin","volume":"19","author":"Vance-Bryan","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"2024051617490215300_dkad198-B21","volume-title":"Cipro(R) Oral Tablets, Oral Suspension, Ciprofloxacin Hydrochloride Oral Tablets, Oral Suspension [Package Insert]","year":"2019"},{"key":"2024051617490215300_dkad198-B22","volume-title":"CLEOCIN HCl(R) Oral Capsules, Clindamycin HCl Oral Capsules [Package Insert]","year":"2018"},{"key":"2024051617490215300_dkad198-B23","first-page":"386","article-title":"Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation","volume":"37","author":"Mazur","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2024051617490215300_dkad198-B24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/j.1552-4604.1995.tb04742.x","article-title":"Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients","volume":"35","author":"Gath","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"2024051617490215300_dkad198-B25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2125.1975.tb01566.x","article-title":"Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis","volume":"2","author":"Nauta","year":"1975","journal-title":"Br J Clin Pharmacol"},{"key":"2024051617490215300_dkad198-B26","first-page":"255","article-title":"The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption","volume":"77","author":"Dijkmans","year":"2019","journal-title":"Neth J Med"},{"key":"2024051617490215300_dkad198-B27","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/clinids\/12.Supplement_3.S318","article-title":"Pharmacokinetics and tissue penetration of fluconazole in humans","volume":"12","author":"Brammer","year":"1990","journal-title":"Rev Infect Dis"},{"key":"2024051617490215300_dkad198-B28","volume-title":"DIFLUCAN(R) Oral Tablets, IV Injection, Oral Suspension, Fluconazole Oral Tablets, IV Injection, Oral Suspension","year":"2008"},{"key":"2024051617490215300_dkad198-B29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106166","article-title":"Pharmacokinetic\/pharmacodynamic target attainment of ciprofloxacin in adult patients on general wards with adequate and impaired renal function","volume":"56","author":"de Vroom","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2024051617490215300_dkad198-B30","first-page":"29","article-title":"Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function","volume":"28","author":"Valles","year":"2006","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"2024051617490215300_dkad198-B31","first-page":"37","article-title":"Pharmacokinetics of ciprofloxacin in impaired liver function","volume":"9","author":"Esposito","year":"1989","journal-title":"Int J Clin Pharmacol Res"},{"key":"2024051617490215300_dkad198-B32","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1016\/0002-9343(89)90026-0","article-title":"Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule)","volume":"87","author":"Staib","year":"1989","journal-title":"Am J Med"},{"key":"2024051617490215300_dkad198-B33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2017.10.025","article-title":"Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: the PDER PAN study","volume":"160","author":"Cheung","year":"2017","journal-title":"Thromb Res"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/8\/2008\/57707924\/dkad198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/8\/2008\/57707924\/dkad198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T17:59:55Z","timestamp":1715882395000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/78\/8\/2008\/7214002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,6,30]]},"published-print":{"date-parts":[[2023,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkad198","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,6,30]]}}}